Ángela Roco

449 total citations
21 papers, 288 citations indexed

About

Ángela Roco is a scholar working on Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ángela Roco has authored 21 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ángela Roco's work include Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ángela Roco is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ángela Roco collaborates with scholars based in Chile, Spain and Mexico. Ángela Roco's co-authors include L. Pérez, Luis A. Quiñones, Dante Cáceres, Nelson Varela, José A. G. Agúndez, Elena Garcı́a-Martı́n, N. Farfán, Jana Stojanova, J. Catalan and Cristián Acevedo and has published in prestigious journals such as Phytochemistry, Frontiers in Pharmacology and Journal of Plant Physiology.

In The Last Decade

Ángela Roco

20 papers receiving 274 citations

Peers

Ángela Roco
Doyoung Kwon South Korea
Ángela Roco
Citations per year, relative to Ángela Roco Ángela Roco (= 1×) peers Doyoung Kwon

Countries citing papers authored by Ángela Roco

Since Specialization
Citations

This map shows the geographic impact of Ángela Roco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Roco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Roco more than expected).

Fields of papers citing papers by Ángela Roco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Roco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Roco. The network helps show where Ángela Roco may publish in the future.

Co-authorship network of co-authors of Ángela Roco

This figure shows the co-authorship network connecting the top 25 collaborators of Ángela Roco. A scholar is included among the top collaborators of Ángela Roco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángela Roco. Ángela Roco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivas, Héctor Enrique Torres, et al.. (2021). Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular. Revista médica de Chile. 149(5). 724–732. 1 indexed citations
2.
Roco, Ángela, et al.. (2020). A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study. Frontiers in Pharmacology. 11. 325–325. 6 indexed citations
3.
Roco, Ángela, María Paz Bertoglia, Elena Nieto, et al.. (2020). Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and Applied Thrombosis/Hemostasis. 26. 2874307682–2874307682. 3 indexed citations
4.
Roco, Ángela, Berta de la Cerda, Elena Garcı́a-Martı́n, et al.. (2019). Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in Pharmacology. 10. 206–206. 12 indexed citations
5.
Roco, Ángela, Cristián Acevedo, Elena Garcı́a-Martı́n, et al.. (2019). The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer. Pharmacogenetics and Genomics. 29(7). 159–166. 6 indexed citations
6.
Roco, Ángela, et al.. (2019). Estudio comparativo de equipos INR capilar “point of care” versus INR venoso, en pacientes en tratamiento con antagonistas de vitamina K. Revista médica de Chile. 147(10). 1273–1282. 1 indexed citations
7.
Roco, Ángela, et al.. (2018). Farmacogenética, tabaco, alcohol y su efecto sobre el riesgo de desarrollar cáncer. Revista chilena de pediatría. 89(ahead). 0–0. 4 indexed citations
8.
Quiñones, Luis A., et al.. (2017). Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica. Revista médica de Chile. 145(4). 483–500. 16 indexed citations
9.
Nieto, Elena, et al.. (2016). Impacto de Ia Telemedicina en Ia calidad del Control de Tratamiento Anticoagulante Oral. Revista chilena de cardiología. 35(1). 25–31.
10.
Roco, Ángela, et al.. (2015). Prevalence of seven cardiovascular-related genetic polymorphisms in a Chilean mestizo healthy population. Acta cardiologica. Supplementum. 70(5). 528–535. 3 indexed citations
11.
Acevedo, Cristián, Luis A. Quiñones, J. Catalan, et al.. (2014). Impact of CYP1A1, GSTM1, and GSTT1 polymorphisms in overall and specific prostate cancer survival. Urologic Oncology Seminars and Original Investigations. 32(3). 280–290. 10 indexed citations
12.
Roco, Ángela, et al.. (2014). Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?. Frontiers in Genetics. 5. 391–391. 25 indexed citations
13.
Roco, Ángela, Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, et al.. (2012). MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. Journal of Neural Transmission. 120(3). 463–467. 16 indexed citations
14.
Roco, Ángela, Luis A. Quiñones, José A. G. Agúndez, et al.. (2012). Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations. Frontiers in Genetics. 3. 229–229. 57 indexed citations
15.
Quiñones, Luis A., et al.. (2012). Influencia de polimorfismos genéticos de CYP3A4/5 en la farmacocinética de levonorgestrel: estudio piloto. Biomédica. 32(4). 570–7. 14 indexed citations
16.
Roco, Ángela, et al.. (2011). Determinación del polimorfismo de CYP2C9*2 y su relación con la farmacocinética de acenocumarol en voluntarios sanos. Revista chilena de cardiología. 30(3). 218–224. 2 indexed citations
17.
Espinoza, Iris, et al.. (2010). Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oncology Letters. 1(3). 549–553. 20 indexed citations
18.
Pérez, L. & Ángela Roco. (2001). In vitro biocontrol activity of Trichoderma harzianum on Alternaria alternata in the presence of growth regulators. Electronic Journal of Biotechnology. 4(2). 65 indexed citations
19.
Roco, Ángela, et al.. (1993). Oligosaccharides released by pectinase treatment of Citrus limon seedlings are elicitors of the plant response. Phytochemistry. 33(6). 1301–1306. 21 indexed citations
20.
Chiong, Mario, et al.. (1993). Antibodies against Fungal Conidia and Antibiotics Inhibit Phenylalanine Ammonia-Lyase Activation in Citrus. Journal of Plant Physiology. 141(4). 393–397. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026